Investigating new treatments for opioid addiction in Appalachia.
Appalachian Node
This study is looking for new ways to help people in the Appalachian region who are dealing with opioid misuse and addiction, and it’s designed for anyone who wants to find better treatment options in their community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11062103 on NIH RePORTER |
What this research studies
This research focuses on developing and testing innovative strategies to improve treatment for individuals struggling with opioid misuse and addiction, particularly in the Appalachian region. It is part of the NIH’s HEAL initiative, which aims to address the opioid crisis through collaborative efforts among several universities and health systems. The project will involve clinical trials that assess the effectiveness of various interventions in diverse communities, including urban and rural populations. By utilizing harmonized electronic health records, the research aims to gather comprehensive data to inform better treatment approaches.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals in the Appalachian region or nearby urban areas who are struggling with opioid use disorder.
Not a fit: Patients who do not have opioid use disorder or those living outside the targeted geographic areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for opioid addiction, ultimately reducing overdose deaths and improving the lives of those affected.
How similar studies have performed: Previous research within the NIH HEAL initiative has shown promise in developing effective interventions for opioid addiction, indicating a strong potential for success in this collaborative approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Liebschutz, Jane M — University of Pittsburgh at Pittsburgh
- Study coordinator: Liebschutz, Jane M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.